Following the success of Wrexham’s recent case study. Our sister company, AB Molecular, have now issued a further case study.
15th Dec, 2021Public Health Wales (Bronglais General Hospital)
Following the success of Wrexham’s recent case study. Our sister company, AB Molecular, have now issued a further case study.
Bronglais Hospital’s journey with the ePlex began in January 2020 as part of the Public Health Wales’ implementation of the Blood Culture Identification (BCID) panels throughout it’s labs.
The case study takes you through the issues the hospital faced prior to the implementation, the solution the ePlex offered and the clinical outcomes.
Give it a read here!